Regadenoson Injection, Solution
Product Images NDC 83032-001

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Regadenoson (NDC 83032-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Indies Pharma Jamaica Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pfs Carton (Regadenoson Pfs Carton)

Regadenoson Injection 0.4 mg/5 mL (0.08 mg/mL) single-dose pre-filled syringe for intravenous use. The labeling includes dosage strength, administration instructions, sterile syringe illustration, and manufacturer information. The product is labeled for Rx only and is produced by Indies Pharma Jamaica Limited.*

FDA Label Image

Pfs Label (Regadenoson Pfs Label)

Label for Regadenoson Injection 0.4 mg/5 mL (0.08 mg/mL) in a 5 mL single-dose pre-filled syringe. The label indicates it is for intravenous use only and for pharmacologic stress only. Manufactured for Indies Pharma Jamaica Limited, Montego Bay, Jamaica, made in India, with an issue date of 08/2023. Includes NDC 83032-001-01 and a barcode. The label is marked Rx only.*

FDA Label Image

Regadenoson-structure (Regadenoson Structure)

Chemical structure diagram of Regadenoson showing the molecular arrangement of atoms including nitrogen, oxygen, and carbon elements in the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.